What Should Be the Best Approach Post-liver Resection in Non-viral Non-cirrhotic Hepatocellular Carcinoma?

Overview

Journal Hepatobiliary Surg Nutr

Publisher AME Publishing Company

Date 2024 Jun 24

PMID 38911205

Authors

Mariana Verdelho Machado

Affiliations

Soon will be listed here.

References

Mohamad B, Shah V, Onyshchenko M, Elshamy M, Aucejo F, Lopez R . Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. Hepatol Int. 2015; 10(4):632-9. DOI: 10.1007/s12072-015-9679-0. View

Bengtsson B, Stal P, Wahlin S, Bjorkstrom N, Hagstrom H . Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis. Liver Int. 2019; 39(6):1098-1108. DOI: 10.1111/liv.14087. View

Verdelho Machado M . The Growing Landscape of NAFLD-Associated Hepatocellular Carcinoma and Its Impact in Surveillance. GE Port J Gastroenterol. 2024; 31(1):14-23. PMC: 10836954. DOI: 10.1159/000531397. View

Gawrieh S, Dakhoul L, Miller E, Scanga A, deLemos A, Kettler C . Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study. Aliment Pharmacol Ther. 2019; 50(7):809-821. DOI: 10.1111/apt.15464. View

Mittal S, El-Serag H, Sada Y, Kanwal F, Duan Z, Temple S . Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2015; 14(1):124-31.e1. PMC: 4690789. DOI: 10.1016/j.cgh.2015.07.019. View

Maulat C, Truant S, Hobeika C, Barbier L, Herrero A, Doussot A . Prognostication algorithm for non-cirrhotic non-B non-C hepatocellular carcinoma-a multicenter study under the aegis of the French Association of Hepato-Biliary Surgery and liver Transplantation. Hepatobiliary Surg Nutr. 2023; 12(2):192-204. PMC: 10129883. DOI: 10.21037/hbsn-22-33. View

Zhou Y, Lei X, Wu L, Wu X, Xu D, Li B . Outcomes of hepatectomy for noncirrhotic hepatocellular carcinoma: a systematic review. Surg Oncol. 2014; 23(4):236-42. DOI: 10.1016/j.suronc.2014.11.001. View

Liu T, Vachharajani N, Chapman W, Brunt E . Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis. Mod Pathol. 2013; 27(3):420-32. PMC: 5861497. DOI: 10.1038/modpathol.2013.148. View

Verdelho Machado M, Diehl A . Pathogenesis of Nonalcoholic Steatohepatitis. Gastroenterology. 2016; 150(8):1769-77. PMC: 4887389. DOI: 10.1053/j.gastro.2016.02.066. View

10.

Verdelho Machado M . Hepatocellular carcinoma screening in NAFLD: The paradox of nearly half the cases arising in non-cirrhotic low risk patients. Ann Hepatol. 2023; 28(3):101101. DOI: 10.1016/j.aohep.2023.101101. View

11.

Pinyopornpanish K, Al-Yaman W, Dasarathy S, Romero-Marrero C, McCullough A . Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival. Dig Dis Sci. 2021; 67(6):2677-2687. PMC: 9087017. DOI: 10.1007/s10620-021-07048-5. View

12.

Qin S, Chen M, Cheng A, Kaseb A, Kudo M, Lee H . Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial. Lancet. 2023; 402(10415):1835-1847. DOI: 10.1016/S0140-6736(23)01796-8. View

13.

Filliol A, Saito Y, Nair A, Dapito D, Yu L, Ravichandra A . Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature. 2022; 610(7931):356-365. PMC: 9949942. DOI: 10.1038/s41586-022-05289-6. View